criteria for glp-1 Who Qualifies Semaglutide Injections for Weight Loss? BMI for GLP-1: what body

Moderna's Covid-19 shot settlement, Prime Medicine's gene therapy, and other biotech news from The Readout

Divergence across payer type matters: Commercial patients adopt GLP1s earlier and often remain on monotherapy, while Medicare patients face stricter controls and higher comorbidity burdens

For GLP-1 Users: GLP-1 medications actively slow gastric emptying, frequently leading to stubborn constipation

Getting a GLP-1 prescription for weight loss no longer requires navigating insurance denials or expensive brand-name medications

The primary goal of this article is to emphasize the extensive benefits of using GLP-1RAs in treating a broad spectrum of diseases, such as obesity, cardiovascular diseases, non-alcoholic fatty liver disease (NAFLD), neurodegenerative diseases, musculoskeletal inflammation, and various forms of cancer